Response to "assessment of risk of ALS conferred by the GGGGCC hexanucleotide expansion in C9orf72 among first-degree relatives of patients with ALS carrying the repeat expansion".
Resource Type
Academic Journal
Authors
Dratch L; Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.; Kinnamon DD; Division of Human Genetics, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Harrington EA; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.; Goldman J; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.; Fong JC; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.; Department of Neurology, Memory and Aging Center, University of California-San Francisco, San Francisco, CA, USA.; Jones T; Neurosciences Department, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Uhlmann WR; Division of Genetic Medicine, Department of Internal Medicine; Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA, and.; Roggenbuck J; Division of Human Genetics, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Source
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101587185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2167-9223 (Electronic) Linking ISSN: 21678421 NLM ISO Abbreviation: Amyotroph Lateral Scler Frontotemporal Degener Subsets: MEDLINE